Search results for "Precision medicine."

showing 10 items of 211 documents

The regulatory landscape for actively personalized cancer immunotherapies

2013

Oncologymedicine.medical_specialtybusiness.industryBiomedical EngineeringCancerBioengineeringmedicine.diseaseCancer VaccinesApplied Microbiology and BiotechnologySocial Control FormalDrug developmentNeoplasmsInternal medicineImmunologyBiomarkers TumormedicineHumansMolecular MedicineImmunotherapyPrecision MedicinebusinessBiotechnologyNature Biotechnology
researchProduct

Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress

2020

Gastroesophageal adenocarcinoma (GEA) represents a heterogeneous disease and, when diagnosed as locally advanced or metastatic, it is characterized by poor prognosis. During the last few years, several molecular classifications have been proposed to try to personalize treatment for those patients diagnosed with advanced disease. Nevertheless, despite the great effort, precision medicine is still far from being a reality. The improvement in the molecular analysis due to the application of high throughput technologies based on DNA and RNA sequencing has opened a novel scenario leading to the personalization of treatment. The possibility to target epidermal growth factor receptor (HER)2, Claud…

Oncologymedicine.medical_specialtymedicine.medical_treatmentprecision medicinePopulationlcsh:MedicineReviewDisease03 medical and health sciences0302 clinical medicineInternal medicinemedicineEpidermal growth factor receptoreducationadvanced gastric cancer030304 developmental biology0303 health scienceseducation.field_of_studyGastroesophageal adenocarcinomabiologybusiness.industrylcsh:RGeneral MedicineImmunotherapyAdvanced gastric cancerPrecision medicineAdvanced gastric cancer; New drug development; Precision medicineFibroblast growth factor receptor030220 oncology & carcinogenesisbiology.proteinnew drug developmentbusinessJournal of Clinical Medicine
researchProduct

Virtual Clinical and Precision Medicine Tumor Boards-Cloud-Based Platform-Mediated Implementation of Multidisciplinary Reviews Among Oncology Centers…

2021

Background Multidisciplinary tumor boards play a pivotal role in the patient-centered clinical management and in the decision-making process to provide best evidence-based, diagnostic, and therapeutic care to patients with cancer. Among the barriers to achieve an efficient multidisciplinary tumor board, lack of time and geographical distance play a major role. Therefore, the elaboration of an efficient virtual multidisciplinary tumor board (VMTB) is a key point to successfully obtain an oncology team and implement a network among health professionals and institutions. This need is stronger than ever during the COVID-19 pandemic. Objective This paper presents a research protocol for an obse…

Oncologymedicine.medical_specialtytumorComputer scienceSettore MED/06 - Oncologia MedicaMultidisciplinary oncology consultationprecision medicinedigital healthSettore MED/42 - Igiene Generale E Applicatavirtual tumor boardPatient satisfactionplatformMultidisciplinary approachInternal medicinemedicineProtocolcancermultidisciplinary oncology consultationsmultidisciplinary communicationvirtual healthhealth servicesimplementationProtocol (science)multidisciplinary collaborationHealth Insurance Portability and Accountability ActCOVID-19General MedicinePrecision medicineDigital healthoncologycloud-basedHealth serviceCustomer satisfactionObservational studyJMIR research protocols
researchProduct

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

2016

Melanoma treatment has been revolutionized by antibody-based immunotherapies. IFNγ secretion by CD8+ T cells is critical for therapy efficacy having anti-proliferative and pro-apoptotic effects on tumour cells. Our study demonstrates a genetic evolution of IFNγ resistance in different melanoma patient models. Chromosomal alterations and subsequent inactivating mutations in genes of the IFNγ signalling cascade, most often JAK1 or JAK2, protect melanoma cells from anti-tumour IFNγ activity. JAK1/2 mutants further evolve into T-cell-resistant HLA class I-negative lesions with genes involved in antigen presentation silenced and no longer inducible by IFNγ. Allelic JAK1/2 losses predisposing to …

Patient-Specific Modeling0301 basic medicineSkin NeoplasmsBiopsyT-LymphocytesDNA Mutational AnalysisDatasets as TopicGeneral Physics and AstronomyAntineoplastic Agents ImmunologicalMutation RatePrecision MedicineMelanomaSkinAntigen PresentationMultidisciplinarybiologyMelanomaQfood and beverages3. Good healthTreatment Outcomemedicine.anatomical_structureImmunotherapyAntibodySignal TransductionScienceT cellAntigen presentationHuman leukocyte antigenArticleGeneral Biochemistry Genetics and Molecular BiologyInterferon-gamma03 medical and health sciencesAntigenAntigens NeoplasmCell Line TumormedicineHumansWhole Genome SequencingHistocompatibility Antigens Class IJanus Kinase 1General ChemistryJanus Kinase 2medicine.disease030104 developmental biologyImmunoeditingDrug Resistance NeoplasmMutationImmunologybiology.proteinTumor EscapeCD8Nature Communications
researchProduct

Epigenetics in spine curvature disorders

2022

Abstract Scoliosis is a three-dimensional (3D) structural deformity of the spine with a radiological lateral Cobb angle of ≥ 10°. Several classification systems exist, dividing different types regarding the age of onset or the type of etiology. The minority of cases are secondary to congenital, syndromic of neuromosucular diseases. Most of the cases are classified “idiopathic” due to unknown etiology. These were formally divided by the age of onset into “Infantile Idiopathic Scoliosis” (0–3 years), “Juvenile Idiopathic Scoliosis” (JIS—4–10 years), and “Adolescent Idiopathic Scoliosis” (AIS → 10 years). Since the initiative of the Scoliosis Research Society in 2014 all kind of scoliosis with…

Pediatricsmedicine.medical_specialtyCobb anglebusiness.industryOsteoporosisScoliosismedicine.diseasePrecision medicinemedicineDeformityEtiologyEpigeneticsmedicine.symptomAge of onsetbusiness
researchProduct

Diet and Neurocognition in Mood Disorders - an Overview of the Overlooked.

2019

Bipolar disorder and major depression are associated with significant disability, morbidity, and reduced life expectancy. People with mood disorders have shown higher ratios of unhealthy lifestyle choices, including poor diet quality and suboptimal nutrition. Diet and nutrition impact on brain /mental health, but cognitive outcomes have been less researched in psychiatric disorders. Neurocognitive dysfunction is a major driver of social dysfunction and a therapeutic target in mood disorders, although effective cognitive-enhancers are currently lacking. This narrative review aimed to assess the potential cognitive benefits of dietary and nutritional interventions in subjects diagnosed with m…

PharmacologyBipolar Disorderbusiness.industryMood DisordersCognitionPrecision medicinemedicine.diseaseMental health030227 psychiatryDietGastrointestinal MicrobiomeClinical trial03 medical and health sciences0302 clinical medicineMood disordersDrug DiscoverymedicineHumansBipolar disorderbusinessCognition DisordersNeurocognitive030217 neurology & neurosurgeryDepression (differential diagnoses)Clinical psychology
researchProduct

Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future.

2012

AbstractOmic techniques have become key tools in the development of systems biology. As the holistic approaches underlying the practice of traditional Chinese medicine (TCM) and new tendencies in Western medicine towards personalised medicine require in-depth knowledge of mechanisms of action and active compounds, the use of omic techniques is crucial for understanding and interpretation of TCM development, especially in view of its expansion in Western countries. In this short review, omic applications in TCM research are reviewed which has allowed some speculation regarding future perspectives for these approaches in TCM modernisation and standardisation. Guidelines for good practice for …

ProteomicsBiomedical ResearchSystems biologyHerbal MedicineMEDLINETraditional Chinese medicineBioinformatics03 medical and health sciencesTraditional Chinese medicine0302 clinical medicineChinese traditionalDrug DiscoveryMetabolomicsMedicineHumansTechnology PharmaceuticalMedicine Chinese TraditionalPrecision MedicineTranscriptomicsGood practice030304 developmental biologyPharmacology0303 health sciencesPlants Medicinalbusiness.industrySystems BiologyGenomicsData science3. Good healthMetabonomics030220 oncology & carcinogenesisChinese herbal medicinebusinessWestern medicineDrugs Chinese HerbalPhytotherapyJournal of ethnopharmacology
researchProduct

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICP…

2016

Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adu…

Pulmonary and Respiratory MedicineGerontologyAllergen immunotherapymedicine.medical_specialtyAllergyAl·lèrgiaEIP on AHAAllergy[SDV]Life Sciences [q-bio]ImmunologyAlternative medicineImmunoteràpiaReview03 medical and health sciences0302 clinical medicinemedicineJournal ArticleImmunology and Allergy030212 general & internal medicineAsthmaAllergen immunotherapyRhinitisbusiness.industryPrecision medicinemedicine.diseaseAsthma3. Good healthIntegrated care[SDV] Life Sciences [q-bio]AgeingAIRWAYS ICPs030228 respiratory systemGeneral partnershipAction planImmunologyImmunotherapybusiness
researchProduct

Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distr…

2019

The effect of personalised mechanical ventilation on clinical outcomes in patients with acute respiratory distress syndrome (ARDS) remains uncertain and needs to be evaluated. We aimed to test whether a mechanical ventilation strategy that was personalised to individual patients' lung morphology would improve the survival of patients with ARDS when compared with standard of care.We designed a multicentre, single-blind, stratified, parallel-group, randomised controlled trial enrolling patients with moderate-to-severe ARDS in 20 university or non-university intensive care units in France. Patients older than 18 years with early ARDS for less than 12 h were randomly assigned (1:1) to either th…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyARDSmedicine.medical_treatment[SDV]Life Sciences [q-bio]law.inventionPositive-Pressure Respiration03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineFraction of inspired oxygenIntensive caremedicineProne PositionTidal VolumeHumansSingle-Blind Method030212 general & internal medicineProspective StudiesPrecision MedicineLungPositive end-expiratory pressureTidal volumeComputingMilieux_MISCELLANEOUSProportional Hazards ModelsMechanical ventilationRespiratory Distress Syndromebusiness.industryHazard ratioMiddle Agedmedicine.diseaseRespiration Artificial3. Good health[SDV] Life Sciences [q-bio]Intensive Care UnitsEditorial CommentaryTreatment Outcome030228 respiratory systemFemaleFrancebusiness
researchProduct

Does large NGS panel analysed using exome tumour sequencing improve the management of advanced non-small-cell lung cancers?

2020

Abstract Introduction Non-small-cell lung cancer (NSCLC) is one of the most common and deadly cancers. Several molecular drivers of oncogene addiction are now known to be strong predictive biomarkers for target therapies. Advances in large Next Generation Sequencing (LNGS) have improved the ability to detect potentially targetable mutations. However, the integration of LNGS into clinical management in an individualized manner remains challenging. Methods In this single-center observational study we included all patients with advanced NSCLC who underwent LNGS. Somatic and germline exome analysis was performed with a restriction on 323 cancer related genes. Variants were classified and Molecu…

Pulmonary and Respiratory MedicineOncologyCancer Researchmedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentGermlineTargeted therapyInternal medicineCarcinoma Non-Small-Cell LungMedicineHumansExomeLung cancerExomeLungbusiness.industryHigh-Throughput Nucleotide SequencingOncogenesPrecision medicinemedicine.diseaseCancer related genesmedicine.anatomical_structureOncologyMutationNon small cellbusinessLung cancer (Amsterdam, Netherlands)
researchProduct